BioSpace News Archive

Diffusion Pharmaceuticals Inc. today announced that the Company has obtained clearance of its Investigational New Drug (IND) application submitted to the U.S. Food and Drug Administration’s (FDA) Pulmonology, Allergy, and Critical Care Division for the company’s lead product candidate, trans sodium crocetinate (TSC).

AnPac Bio-Medical Science Co., Ltd. , today announced that its Philadelphia, PA Clinical Laboratory Improvement Amendments (“CLIA”) certified laboratory has received accreditation from the College of American Pathologists (“CAP”).

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of four data presentations at the upcoming XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL), being held virtually September 17 – 20, 2021.

Apyx Medical Corporation Announces Appointment of Wendy Levine to the Company’s Board of Directors

Rubius Therapeutics, Inc. today announced the appointment of Jim Jogerst as chief business officer.

Poseida Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for P-BCMA-ALLO1, the Company’s first fully allogeneic CAR-T product candidate for patients with relapsed/refractory multiple myeloma.

Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the BofA Global Healthcare Conference on Wednesday, September 15, 2021

Graphite Bio, Inc. today announced that members of the management team will participate in virtual fireside chats at the following investor conferences: Morgan Stanley 19th Annual Global Healthcare Conference on Monday, Sept. 13, 2021

Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at Citi’s 16th Annual BioPharma Conference on Friday, September 10, 2021

Genome Medical today announced that it will acquire GeneMatters